Analysis of Biomechanical Parameters and Return to Sport After Total Hip Replacement

July 8, 2026 updated by: Clinique du Sport, Bordeaux Mérignac
This prospective study aims to evaluate the dynamic biomechanical parameters of gait in active patients who have undergone total hip replacement (THR), focusing on movements critical for return to sport.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Active patients (low to high level of physical activity priori to surgery) with hip osteoarthritis necessiting total hip replacement

Description

Inclusion Criteria:

  • Patient scheduled for total hip replacement surgery
  • Active patient with low to high level of physical activity prior to surgery
  • Informed consent
  • Complete medical file

Exclusion Criteria:

  • Contralateral hip surgery
  • Neurological disorder affecting movement (e.g. Parkinson's disease, stroke)
  • Spinal pathology affecting movement or posture
  • Dementia or inability to complete questionnaires and assessments
  • Pregnant or breast-feeding patient
  • Patient under protective supervision
  • Patient not covered by a social security scheme

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Biomechanical analysis
Procedure: Biomechanical analysis
Biomechanical assessment is performed using a set of sensors (Qualisys Sports Marker Set - functional assessment, already in use at the Clinique du Sport) as well as 3D optoelectronic cameras and force and pressure platforms. These sensors are placed at various points on both lower limbs (hip, knee, ankle) and provide data in different planes (sagittal, frontal, transverse), as well as a comparison of both sides.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Angular measurements by biomechanical sensors
Time Frame: 6 months after surgery
Angle measurements at hip, pelvis, knee and ankle in the three planes of space (sagittal, frontal and transverse), measured by biomechanical sensors.
6 months after surgery
Vertical forces measured by biomechanical sensors
Time Frame: 6 months after surgery
Vertical forces, push and landing, will be evaluated for each phase of the movements. Biomechanical specific sensors will be used to measure these data
6 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Clinique du Sport, Bordeaux Mérignac

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 30, 2025

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

January 31, 2027

Study Registration Dates

First Submitted

January 13, 2025

First Submitted That Met QC Criteria

January 28, 2025

First Posted (Actual)

January 31, 2025

Study Record Updates

Last Update Posted (Actual)

July 9, 2026

Last Update Submitted That Met QC Criteria

July 8, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2024-31-SBM

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe